Streeck Hendrik, Brumme Zabrina L, Anastario Michael, Cohen Kristin W, Jolin Jonathan S, Meier Angela, Brumme Chanson J, Rosenberg Eric S, Alter Galit, Allen Todd M, Walker Bruce D, Altfeld Marcus
Partners AIDS Research Center, Infectious Disease Unit, Massachusetts General Hospital and Division of AIDS, Harvard Medical School, Boston, Massachusetts, United States of America.
PLoS Med. 2008 May 6;5(5):e100. doi: 10.1371/journal.pmed.0050100.
Virus-specific CD8(+) T lymphocytes play a key role in the initial reduction of peak viremia during acute viral infections, but display signs of increasing dysfunction and exhaustion under conditions of chronic antigen persistence. It has been suggested that virus-specific CD8(+) T cells with a "polyfunctional" profile, defined by the capacity to secrete multiple cytokines or chemokines, are most competent in controlling viral replication in chronic HIV-1 infection. We used HIV-1 infection as a model of chronic persistent viral infection to investigate the process of exhaustion and dysfunction of virus-specific CD8(+) T cell responses on the single-epitope level over time, starting in primary HIV-1 infection.
We longitudinally analyzed the polyfunctional epitope-specific CD8(+) T cell responses of 18 patients during primary HIV-1 infection before and after therapy initiation or sequence variation in the targeted epitope. Epitope-specific CD8(+) T cells responded with multiple effector functions to antigenic stimulation during primary HIV-1 infection, but lost their polyfunctional capacity in response to antigen and up-regulated programmed death 1 (PD-1) expression with persistent viremic infection. This exhausted phenotype significantly decreased upon removal of stimulation by antigen, either in response to antiretroviral therapy or by reduction of epitope-specific antigen load in the presence of ongoing viral replication, as a consequence of in vivo selection of cytotoxic T lymphocyte escape mutations in the respective epitopes. Monofunctionality increased in CD8(+) T cell responses directed against conserved epitopes from 49% (95% confidence interval 27%-72%) to 76% (56%-95%) (standard deviation [SD] of the effect size 0.71), while monofunctionality remained stable or slightly decreased for responses directed against escaped epitopes from 61% (47%-75%) to 56% (42%-70%) (SD of the effect size 0.18) (p < 0.05).
These data suggest that persistence of antigen can be the cause, rather than the consequence, of the functional impairment of virus-specific T cell responses observed during chronic HIV-1 infection, and underscore the importance of evaluating autologous viral sequences in studies aimed at investigating the relationship between virus-specific immunity and associated pathogenesis.
病毒特异性CD8(+)T淋巴细胞在急性病毒感染期间对病毒血症峰值的初始降低起关键作用,但在慢性抗原持续存在的情况下会表现出功能障碍和耗竭加剧的迹象。有人提出,具有“多功能”特征(由分泌多种细胞因子或趋化因子的能力定义)的病毒特异性CD8(+)T细胞在慢性HIV-1感染中最有能力控制病毒复制。我们以HIV-1感染作为慢性持续性病毒感染的模型,从原发性HIV-1感染开始,研究病毒特异性CD8(+)T细胞反应在单表位水平上随时间推移的耗竭和功能障碍过程。
我们纵向分析了18例患者在原发性HIV-1感染期间、治疗开始前后或靶向表位序列变异前后的多功能表位特异性CD8(+)T细胞反应。在原发性HIV-1感染期间,表位特异性CD8(+)T细胞对抗原刺激会产生多种效应功能,但随着持续性病毒血症感染,它们对抗原的反应失去了多功能能力,并上调了程序性死亡1(PD-1)的表达。这种耗竭表型在去除抗原刺激后显著降低,这要么是由于抗逆转录病毒治疗,要么是由于在病毒持续复制的情况下表位特异性抗原负荷降低,这是由于体内对各个表位的细胞毒性T淋巴细胞逃逸突变进行选择的结果。针对保守表位的CD8(+)T细胞反应中的单功能比例从49%(95%置信区间27%-72%)增加到76%(56%-95%)(效应大小的标准差[SD]为0.71),而针对逃逸表位的反应中,单功能比例从61%(47%-75%)保持稳定或略有下降至56%(42%-70%)(效应大小的SD为0.18)(p<0.05)。
这些数据表明,抗原的持续存在可能是慢性HIV-1感染期间观察到的病毒特异性T细胞反应功能受损的原因,而非结果,并强调了在旨在研究病毒特异性免疫与相关发病机制之间关系的研究中评估自体病毒序列的重要性。